Whole-genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles
- PMID: 39226462
- PMCID: PMC11600029
- DOI: 10.1182/blood.2023022596
Whole-genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles
Abstract
Genetic studies have identified numerous regions associated with plasma fibrinogen levels in Europeans, yet missing heritability and limited inclusion of non-Europeans necessitates further studies with improved power and sensitivity. Compared with array-based genotyping, whole-genome sequencing (WGS) data provide better coverage of the genome and better representation of non-European variants. To better understand the genetic landscape regulating plasma fibrinogen levels, we meta-analyzed WGS data from the National Heart, Lung, and Blood Institute's Trans-Omics for Precision Medicine (TOPMed) program (n = 32 572), with array-based genotype data from the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (n = 131 340) imputed to the TOPMed or Haplotype Reference Consortium panel. We identified 18 loci that have not been identified in prior genetic studies of fibrinogen. Of these, 4 are driven by common variants of small effect with reported minor allele frequency (MAF) at least 10 percentage points higher in African populations. Three signals (SERPINA1, ZFP36L2, and TLR10) contain predicted deleterious missense variants. Two loci, SOCS3 and HPN, each harbor 2 conditionally distinct, noncoding variants. The gene region encoding the fibrinogen protein chain subunits (FGG;FGB;FGA) contains 7 distinct signals, including 1 novel signal driven by rs28577061, a variant common in African ancestry populations but extremely rare in Europeans (MAFAFR = 0.180; MAFEUR = 0.008). Through phenome-wide association studies in the VA Million Veteran Program, we found associations between fibrinogen polygenic risk scores and thrombotic and inflammatory disease phenotypes, including an association with gout. Our findings demonstrate the utility of WGS to augment genetic discovery in diverse populations and offer new insights for putative mechanisms of fibrinogen regulation.
Conflict of interest statement
Conflict-of-interest disclosure: L.R. is a consultant for the TOPMed Administrative Coordinating Center (through WeStat). R.L.-G. is a part-time consultant for Metabolon, Inc. M.C. has received grant support from Bayer. B.P. serves on the Steering Committee of the Yale Open Data Access Project, funded by Johnson & Johnson. In the past 3 years, E.K.S. has received grant support from Bayer. The remaining authors declare no competing financial interests.
A complete list of the members of the VA Million Veteran Program and the National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine (TOPMed) Consortium appears in the supplemental Data.
Update of
-
Whole genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles.medRxiv [Preprint]. 2023 Jun 12:2023.06.07.23291095. doi: 10.1101/2023.06.07.23291095. medRxiv. 2023. Update in: Blood. 2024 Nov 21;144(21):2248-2265. doi: 10.1182/blood.2023022596. PMID: 37398003 Free PMC article. Updated. Preprint.
References
-
- Fibrinogen Studies Collaboration. Danesh J, Lewington S. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA. 2005;294(14):1799–1809. - PubMed
MeSH terms
Substances
Grants and funding
- R01 HL113323/HL/NHLBI NIH HHS/United States
- R01 HL139553/HL/NHLBI NIH HHS/United States
- R01 HL105756/HL/NHLBI NIH HHS/United States
- R01 MD012564/MD/NIMHD NIH HHS/United States
- P01 HL045522/HL/NHLBI NIH HHS/United States
- R01 HL117626/HL/NHLBI NIH HHS/United States
- R01 HL134894/HL/NHLBI NIH HHS/United States
- I01 BX004821/BX/BLRD VA/United States
- R01 HL120393/HL/NHLBI NIH HHS/United States
- U01 HL120393/HL/NHLBI NIH HHS/United States
- R01 HL153805/HL/NHLBI NIH HHS/United States
- R01 HL126974/HL/NHLBI NIH HHS/United States
- HHSN268201800001C/HL/NHLBI NIH HHS/United States
- R01 HL141291/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous